Cancer — Utilizing Novel Information Technology to Promote Exercise and Well-Being in Adolescents and Young Adults With Cancer
Citation(s)
Barakat LP, Galtieri LR, Szalda D, Schwartz LA Assessing the psychosocial needs and program preferences of adolescents and young adults with cancer. Support Care Cancer. 2016 Feb;24(2):823-832. doi: 10.1007/s00520-015-2849-8. Epub 2015 Jul 21.
Bourdon A, Grandy SA, Keats MR Aerobic exercise and cardiopulmonary fitness in childhood cancer survivors treated with a cardiotoxic agent: a meta-analysis. Support Care Cancer. 2018 Jul;26(7):2113-2123. doi: 10.1007/s00520-018-4208-z. Epub 2018 Apr 18.
Cheung CK, Zebrack B What do adolescents and young adults want from cancer resources? Insights from a Delphi panel of AYA patients. Support Care Cancer. 2017 Jan;25(1):119-126. doi: 10.1007/s00520-016-3396-7. Epub 2016 Aug 31.
Cormie P, Zopf EM, Zhang X, Schmitz KH The Impact of Exercise on Cancer Mortality, Recurrence, and Treatment-Related Adverse Effects. Epidemiol Rev. 2017 Jan 1;39(1):71-92. doi: 10.1093/epirev/mxx007.
McCarthy MC, McNeil R, Drew S, Dunt D, Kosola S, Orme L, Sawyer SM Psychological Distress and Posttraumatic Stress Symptoms in Adolescents and Young Adults with Cancer and Their Parents. J Adolesc Young Adult Oncol. 2016 Dec;5(4):322-329. doi: 10.1089/jayao.2016.0015. Epub 2016 May 23.
McCarthy MC, McNeil R, Drew S, Orme L, Sawyer SM Information needs of adolescent and young adult cancer patients and their parent-carers. Support Care Cancer. 2018 May;26(5):1655-1664. doi: 10.1007/s00520-017-3984-1. Epub 2017 Dec 8.
Mendonca G, Cheng LA, Melo EN, de Farias Junior JC Physical activity and social support in adolescents: a systematic review. Health Educ Res. 2014 Oct;29(5):822-39. doi: 10.1093/her/cyu017. Epub 2014 May 8.
Perales MA, Drake EK, Pemmaraju N, Wood WA Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer. Curr Hematol Malig Rep. 2016 Dec;11(6):449-455. doi: 10.1007/s11899-016-0313-6.
Powell KE, Heath GW, Kresnow MJ, Sacks JJ, Branche CM Injury rates from walking, gardening, weightlifting, outdoor bicycling, and aerobics. Med Sci Sports Exerc. 1998 Aug;30(8):1246-9. doi: 10.1097/00005768-199808000-00010.
Quinn GP, Goncalves V, Sehovic I, Bowman ML, Reed DR Quality of life in adolescent and young adult cancer patients: a systematic review of the literature. Patient Relat Outcome Meas. 2015 Feb 17;6:19-51. doi: 10.2147/PROM.S51658. eCollection 2015.
Schmitz KH Incorporating Strength Training into Cancer Care: Translating PAL into the Strength After Breast Cancer Program. Obesity (Silver Spring). 2017 Nov;25 Suppl 2:S32-S33. doi: 10.1002/oby.22018. No abstract available.
Teodozio CGC, Chaves GV, Arcuri IP, Frajacomo FT Does grip strength decrease in the very early stages of hematological treatment? Support Care Cancer. 2018 Feb;26(2):333-335. doi: 10.1007/s00520-017-3932-0. Epub 2017 Oct 23.
Zhang X, McClean D, Ko E, Morgan MA, Schmitz K Exercise Among Women With Ovarian Cancer: A Feasibility and Pre-/Post-Test Exploratory Pilot Study. Oncol Nurs Forum. 2017 May 1;44(3):366-374. doi: 10.1188/17.ONF.366-374.
AYA-UNITE (Utilizing Novel Information Technology to Promote Exercise and Well-Being)
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.